share_log

中源协和(600645.SH):合成生物的概念比较广,目前公司专注于干细胞药物的研发

Zhongyuan Kyowa (600645.SH): The concept of synthetic biology is quite broad. Currently, the company focuses on the development of stem cell drugs

Gelonghui Finance ·  May 8 04:11

Gelonghui, May 8, 丨 Zhongyuan Xiehe (600645.SH) said on the investor interactive platform that the company's main business includes preparation and storage of cell tests in the field of “precision prevention”; research, production and marketing of in vitro diagnostic raw materials, in vitro diagnostic reagents and devices in the field of “accurate diagnosis”; research and development of clinical applications of stem cells and immune cells in the “cell therapy” field; forming a “precision medicine” industry chain. The concept of synthetic biology is quite broad. Currently, the company focuses on the research and development of stem cell drugs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment